Market Overview:
The global iron sucrose injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of anemia, rising geriatric population, and growing demand for parenteral iron preparations. By type, the 50 mg/2.5 mL Venofer segment is expected to account for the largest share of the global iron sucrose injection market in 2018, followed by the 100 mg/5 mL Venofer and 200 mg/10 mL Venofer segments. By application, adult patients are expected to account for the largest share of the global iron sucrose injection market in 2018, followed by pediatric patients.
Product Definition:
Iron sucrose injection is a medication used to treat iron deficiency anemia. It is given by injection into a vein. Iron sucrose injection is important because it can help increase red blood cell count, which can improve symptoms of anemia.
50 mg/2.5 Ml Venofer:
50 mg/2.5 ml venofer is a drug used in the treatment of iron deficiency anemia caused by chronic blood loss. It works by increasing the amount of hemoglobin produced in the body, thereby increasing red blood cell count and improving oxygen delivery to tissues.
100 mg/5 mL Venofer:
Venofer (100 mg/5 mL) is a clear, colorless solution and it's used in the preparation of iron sucrose injection. It helps to treat anemia caused due to blood loss or chronic disease such as cancer.
Venofer 100 mg/5mL Solution for Injection USP is manufactured by Bio-Rad Laboratories, Inc., California 94096 USA and distributed by Bioniche Life Sciences Pvt Ltd., India.
Application Insights:
The application segment includes the use of IV iron sucrose in the treatment of adult and pediatric patients. In 2017, the adult segment dominated with a revenue share of over 80%. The high usage rate and preference for using this compound as an alternative to ferric hydroxide therapy are some factors that can be attributed to its higher market share in this segment.
In addition, several advantages associated with iron sucrose injection such as rapid absorption by cells; enhanced solubility which allows for better compatibility with various other drugs; reduced risk of irritation compared to oral forms such as ferrous sulfate; ease in administration make it suitable for treating adults. However, due to lack of studies regarding its usage rates and proper dosage recommendations especially pertaining to children below 6 years age group is considered a concern area by healthcare professionals across the globe.
Regional Analysis:
North America dominated the global iron sucrose injection market in 2017. The region is expected to witness a CAGR of XX% during the forecast period. Increasing prevalence of chronic kidney diseases and cardiovascular disorders are some of the major factors responsible for high demand for IV iron Sucrose Injection in North America. According to NCBI, around 25 million people suffer from CKD in U.S., which is projected to rise to 39 million by 2030 with an aging population increase and obesity epidemic (NCBI). Iron deficiency anemia is one of the most common forms of anemia among children & adolescents (0-19 years) that affect around 10% - 15% kids across North America (CDC).
In Asia Pacific, ferric carboxymaltose accounted for more than 80% share owing its low cost as compared Venofer brand products used in U.S.
Growth Factors:
- Increasing prevalence of anemia: The increasing prevalence of anemia is one of the major growth drivers for the Iron Sucrose Injection market. According to a study by World Health Organization (WHO), it is estimated that around 2 billion people are affected by anemia, out of which majority are from developing countries. This number is expected to increase in the coming years due to the rising population and changing lifestyle habits. Anemic patients are more likely to suffer from other health complications such as heart disease, stroke, and cognitive decline. Thus, there is a growing demand for effective treatments for anemia, which will drive the growth of Iron Sucrose Injection market in the coming years.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this trend is particularly prominent in developed countries. By 2030, it has been predicted that around 1 in 5 people will be aged 65 or above globally. This rise in geriatric population will lead to increased incidence rates of age-related health conditions such as dementia, arthritis, and cardiovascular diseases among others . As these conditions often require treatment with iron supplements or injections such as Iron Sucrose Injection , there will be a corresponding increase in demand for these products over time , driving market growth .
Scope Of The Report
Report Attributes
Report Details
Report Title
Iron Sucrose Injection Market Research Report
By Type
50 mg/2.5 Ml Venofer, 100 mg/5 mL Venofer, 200 mg/10 mL Venofer, Ferric Carboxymaltose
By Application
Adult, Pediatric
By Companies
Daiichi Sankyo, Alkem Laboratories, Alembic Pharmaceuticals Ltd., Emcure Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Iron Sucrose Injection Market Report Segments:
The global Iron Sucrose Injection market is segmented on the basis of:
Types
50 mg/2.5 Ml Venofer, 100 mg/5 mL Venofer, 200 mg/10 mL Venofer, Ferric Carboxymaltose
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Pediatric
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Daiichi Sankyo
- Alkem Laboratories
- Alembic Pharmaceuticals Ltd.
- Emcure Pharma
Highlights of The Iron Sucrose Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50 mg/2.5 Ml Venofer
- 100 mg/5 mL Venofer
- 200 mg/10 mL Venofer
- Ferric Carboxymaltose
- By Application:
- Adult
- Pediatric
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Iron Sucrose Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Iron sucrose injection is a medication used to treat iron deficiency anemia. It is given by injection into a vein. Iron sucrose injection helps the body absorb and use iron more effectively.
Some of the major players in the iron sucrose injection market are Daiichi Sankyo, Alkem Laboratories, Alembic Pharmaceuticals Ltd., Emcure Pharma.
The iron sucrose injection market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Iron Sucrose Injection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Iron Sucrose Injection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Iron Sucrose Injection Market - Supply Chain
4.5. Global Iron Sucrose Injection Market Forecast
4.5.1. Iron Sucrose Injection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Iron Sucrose Injection Market Size (000 Units) and Y-o-Y Growth
4.5.3. Iron Sucrose Injection Market Absolute $ Opportunity
5. Global Iron Sucrose Injection Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Iron Sucrose Injection Market Size and Volume Forecast by Type
5.3.1. 50 mg/2.5 Ml Venofer
5.3.2. 100 mg/5 mL Venofer
5.3.3. 200 mg/10 mL Venofer
5.3.4. Ferric Carboxymaltose
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Iron Sucrose Injection Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Iron Sucrose Injection Market Size and Volume Forecast by Application
6.3.1. Adult
6.3.2. Pediatric
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Iron Sucrose Injection Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Iron Sucrose Injection Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Iron Sucrose Injection Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Iron Sucrose Injection Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Iron Sucrose Injection Demand Share Forecast, 2019-2026
9. North America Iron Sucrose Injection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Iron Sucrose Injection Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Iron Sucrose Injection Market Size and Volume Forecast by Application
9.4.1. Adult
9.4.2. Pediatric
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Iron Sucrose Injection Market Size and Volume Forecast by Type
9.7.1. 50 mg/2.5 Ml Venofer
9.7.2. 100 mg/5 mL Venofer
9.7.3. 200 mg/10 mL Venofer
9.7.4. Ferric Carboxymaltose
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Iron Sucrose Injection Demand Share Forecast, 2019-2026
10. Latin America Iron Sucrose Injection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Iron Sucrose Injection Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Iron Sucrose Injection Market Size and Volume Forecast by Application
10.4.1. Adult
10.4.2. Pediatric
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Iron Sucrose Injection Market Size and Volume Forecast by Type
10.7.1. 50 mg/2.5 Ml Venofer
10.7.2. 100 mg/5 mL Venofer
10.7.3. 200 mg/10 mL Venofer
10.7.4. Ferric Carboxymaltose
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Iron Sucrose Injection Demand Share Forecast, 2019-2026
11. Europe Iron Sucrose Injection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Iron Sucrose Injection Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Iron Sucrose Injection Market Size and Volume Forecast by Application
11.4.1. Adult
11.4.2. Pediatric
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Iron Sucrose Injection Market Size and Volume Forecast by Type
11.7.1. 50 mg/2.5 Ml Venofer
11.7.2. 100 mg/5 mL Venofer
11.7.3. 200 mg/10 mL Venofer
11.7.4. Ferric Carboxymaltose
11.8. Basis Point Share (BPS) Analysis b Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Iron Sucrose Injection Demand Share, 2019-2026
12. Asia Pacific Iron Sucrose Injection Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Iron Sucrose Injection Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Iron Sucrose Injection Market Size and Volume Forecast by Application
12.4.1. Adult
12.4.2. Pediatric
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Iron Sucrose Injection Market Size and Volume Forecast by Type
12.7.1. 50 mg/2.5 Ml Venofer
12.7.2. 100 mg/5 mL Venofer
12.7.3. 200 mg/10 mL Venofer
12.7.4. Ferric Carboxymaltose
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Iron Sucrose Injection Demand Share, 2019-2026
13. Middle East & Africa Iron Sucrose Injection Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Iron Sucrose Injection Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Iron Sucrose Injection Market Size and Volume Forecast by Application
13.4.1. Adult
13.4.2. Pediatric
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Iron Sucrose Injection Market Size and Volume Forecast by Type
13.7.1. 50 mg/2.5 Ml Venofer
13.7.2. 100 mg/5 mL Venofer
13.7.3. 200 mg/10 mL Venofer
13.7.4. Ferric Carboxymaltose
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Iron Sucrose Injection Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Iron Sucrose Injection Market: Market Share Analysis
14.2. Iron Sucrose Injection Distributors and Customers
14.3. Iron Sucrose Injection Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Daiichi Sankyo
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alkem Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Alembic Pharmaceuticals Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Emcure Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook